Navigation Links
Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
Date:8/25/2013

ests or hepatocellular necrosis, depending upon severity and persistence.
Severe drug-induced liver injury with fatal outcome occurred in 0.3% of 1200 STIVARGA-treated patients across all clinical trials. In metastatic colorectal cancer (mCRC), fatal hepatic failure occurred in 1.6% of patients in the STIVARGA arm and in 0.4% of patients in the placebo arm; all the patients with hepatic failure had metastatic disease in the liver. In gastrointestinal stromal tumor (GIST), fatal hepatic failure occurred in 0.8% of patients in the STIVARGA arm.

Obtain liver function tests (ALT, AST, and bilirubin) before initiation of STIVARGA and monitor at least every 2 weeks during the first 2 months of treatment. Thereafter, monitor monthly or more frequently as clinically indicated. Monitor liver function tests weekly in patients experiencing elevated liver function tests until improvement to less than 3 times the upper limit of normal (ULN) or baseline values. Temporarily hold and then reduce or permanently discontinue STIVARGA, depending on the severity and persistence of hepatotoxicity as manifested by elevated liver function tests or hepatocellular necrosis.

STIVARGA caused an increased incidence of hemorrhage. The overall incidence (Grades 1-5) was 21% and 11% with STIVARGA vs 8% and 3% with placebo in mCRC and GIST patients, respectively. Fatal hemorrhage occurred in 4 of 632 (0.6%) STIVARGA-treated patients and involved the respiratory, gastrointestinal, or genitourinary tracts. Permanently discontinue STIVARGA in patients with severe or life-threatening hemorrhage and monitor INR levels more frequently in patients receiving warfarin.

STIVARGA caused an increased incidence of hand-foot skin reaction (HFSR) (also known as palmar-plantar erythrodysesthesia [PPE]) and severe rash, frequently requiring dose modification. The overall incidence was 45% and 67% with STIVARGA vs 7% and 12% with placebo in mCRC and GIST patients, respectively. Incidence of
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Present at the Baird Growth Stock Conference
4. Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
5. Amgens BiTE® Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
6. Amgen Announces Top-Line Results Of Phase 3 Sensipar®/Mimpara® EVOLVE™ Trial
7. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
8. Amgen Completes Acquisition of KAI Pharmaceuticals
9. Amgens Second Quarter 2012 Revenues Increased 13 Percent To $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent To $1.83
10. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
11. Amgen To Present At The Baird Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... WOONSOCKET, R.I. , Aug. 27, 2014  CVS ... has entered into a new clinical affiliation with MedStar ... in Maryland and the ... access to high-quality, affordable health care services for patients. ... to have access to clinical support, medication counseling, chronic ...
(Date:8/27/2014)... , Aug. 27, 2014 Amgen (NASDAQ: ... Drug Administration (FDA) has granted priority review designation for ... Ivabradine is an oral drug that inhibits the ... sinoatrial node, the body,s cardiac pacemaker. 1 Ivabradine ... on myocardial contractility or ventricular repolarization. 1 Heart ...
(Date:8/27/2014)... Aug. 27, 2014  UBM Medica US announces that ... community for medical imaging professionals, presents special reporting about ... Imaging Management,s 2014 Annual Meeting . ... , 11 Principles of Successful Labor Management ... greater profitability. , Why Don,t Patients Know ...
Breaking Medicine Technology:CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3
... 12 American Life League,s historic Personhood ... in adult stem cell research and regenerative ... Deisher, founder and CEO of AVM Biotechnology ... is speaking on over 17 years of ...
... YORK, Jan. 12 The Michael J. Fox Foundation ... two clinical studies that will test drugs already approved ... disease. Because both drugs being tested are already known ... move swiftly toward regulatory approval for use in Parkinson,s ...
Cached Medicine Technology:Stem Cell Pioneer to Speak to A.L.L. Personhood Conference 2Michael J. Fox Foundation Awards $2.9 Million for Two New Parkinson's Disease Clinical Trials 2
(Date:8/27/2014)... August 27, 2014 Shawna's new book, ... is about Seed Digging, which a brand-new technique she ... models, yet works to bring permanent healing quickly. , ... and mental health disorders cured on a daily basis. ... own minds and find incredible inner peace with only ...
(Date:8/27/2014)... iFitDress.com, a professional company of women’s dresses and related ... bridal gowns . To top it all off, all ... percent off) when buying the company’s new items. ... with these new items. All its online sales representatives ... can gain an enjoyable shopping experience on its website. ...
(Date:8/27/2014)... Seventy-three members of the founding class ... beginning of their careers as healthcare professionals at a ... entering a four-year PharmD program traditionally receive white coats?a ... into the profession as colleagues dedicated to patient care. ... Garrison Theater in Claremont, Calif., KGI President Sheldon Schuster ...
(Date:8/27/2014)... 27, 2014 Ticket Down is ... at Levi’s Stadium in Santa Clara. Levi’s Stadium ... California just opened in July and will host their first ... on Chile. These are two of the best teams that ... Cup and will look to continue their successes from the ...
(Date:8/27/2014)... TN (PRWEB) August 27, 2014 ... Shofner Vision Center see multitudes of patients suffering from ... LASIK and Cataract vision correction surgery . Recently, ... requesting glaucoma information during an eye exam and also ... debunks the top five myths about glaucoma. , 1)    Myth: ...
Breaking Medicine News(10 mins):Health News:Shawna Burns, Counselor, Releases Debut Book, "Seed Digging," to Improve Lives of Children and Adults with Addictions and Mental Health Disorders 2Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4
... the Major Trends in Human Sexual Behavior, Sexual Desire, ... YORK, Nov. 16 , WHAT: Are medicine and technology changing human sexuality? Does ... What role does sex play in the ... and other compelling issues on human sexuality will be the focus of ...
... November 15 - December 31, TULSA, Okla., Nov. ... today that it will offer three Medicare Part D,prescription ... eligible for Medicare. Medicare beneficiaries in Oklahoma can sign,up ... during the 2008,annual open enrollment period, which begins November ...
... November 16, 2007 New research shows that ... a condition marked by unprovoked, intrusive and persistent ... one or several orgasms, are likely to experience ... have this rare and often distressing condition often ...
... American Society of,Consultant Pharmacists (ASCP) announces that PharmMD ... (MTM) Provider Partners. The,announcement was made this week ... Meeting and Exhibition taking place in Philadelphia. ... services has increased,dramatically since the coverage of MTM ...
... leading,provider of clinical software, connectivity and information ... behalf of the National,ePrescribing Patient Safety Initiative ... Medicaid Services (CMS) proposal for the adoption,of ... in the Medicare,prescription drug benefit program when ...
... Aflac Incorporated,announced today that Japan Post Network Co., ... selected Aflac Japan as the exclusive provider,of cancer insurance ... Post Network Co. is one of four separate postal ... of the postal privatization,process set forth under laws enacted ...
Cached Medicine News:Health News:Charlie Rose Science Series 2Health News:Blue Cross and Blue Shield of Oklahoma Announces Flexible, Affordable Blue MedicareRx(SM) Medicare Prescription Drug Plans 2Health News:Genital arousal disorder adversely impacts women's lives 2Health News:PharmMD Becomes an ASCP MTM Provider Partner 2Health News:National ePrescribing Patient Safety Initiative Supports Medicare Proposal to Adopt Additional Standards for ePrescribing 2Health News:National ePrescribing Patient Safety Initiative Supports Medicare Proposal to Adopt Additional Standards for ePrescribing 3Health News:National ePrescribing Patient Safety Initiative Supports Medicare Proposal to Adopt Additional Standards for ePrescribing 4Health News:National ePrescribing Patient Safety Initiative Supports Medicare Proposal to Adopt Additional Standards for ePrescribing 5Health News:Aflac Japan To Offer Cancer Insurance Product Through Japan Post 2Health News:Aflac Japan To Offer Cancer Insurance Product Through Japan Post 3
... for a way to help your patients ... disease? Based on the outcomes of ... (ECP) has improved the quality of their ... normal activities of daily living. , ,MedCath ...
... lab? Worried about the high costs, start-up ... of managing the ongoing business operations? As ... leaving you free to care for your patients., ... convenient diagnostic facility for you and your patients. ...
... currently maintains a large number of mobile, ... in its rental fleet. The labs are ... to several years. The Cath Lab Leasing ... while replacing or upgrading existing equipment, initiating ...
... laser combines excellent cutting, ablation and ... procedures. It is also extremely effective ... stones of all compositions, making it ... its laser light is transmitted through ...
Medicine Products: